

The future of coronary arteries
Feb 14, 2025
In this engaging conversation, Kristy Red-Horse, a Stanford University professor specializing in coronary artery development, unveils groundbreaking research that could revolutionize heart disease treatment. She discusses how innovative molecules like CXCL12 could replace invasive bypass surgeries by stimulating new artery growth. The episode explores challenges in translating animal research to human therapies, advancements in medical imaging, and the importance of a proactive approach to heart health, offering a hopeful glimpse into the future of cardiovascular care.
AI Snips
Chapters
Transcript
Episode notes
Early Intervention for Artery Growth
- Consider medically growing new arteries earlier in the disease process, before a full bypass is needed.
- This could be less invasive than open-heart surgery and improve patient outcomes.
Natural Bypasses: Collateral Arteries
- Collateral arteries act as natural bypasses, rerouting blood flow around blockages.
- However, only about 20% of people naturally grow these collateral arteries in their hearts.
Triggers for Collateral Artery Growth
- Slow-growing blockages trigger a low-oxygen response, potentially stimulating collateral artery growth.
- Genetic factors also influence collateral development, making some individuals more prone.